Michihisa Kono

Aug 29, 2024 | mdpi.com | Risa Wakisaka |Hidekiyo Yamaki |Michihisa Kono |Takahiro Inoue

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Feb 23, 2024 | onlinelibrary.wiley.com | Michihisa Kono |Risa Wakisaka |Hiroki Komatsuda |Ryusuke Hayashi

CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. Supporting Information Filename Description hed27703-sup-0001-FigureS1.pdfPDF document, 50 KB Supplementary Figure 1. Gating strategy of flow cytometric analysis. FITC-conjugated anti-I-A/I-E mAbs were used for negative gating of T cells. hed27703-sup-0002-FigureS2.pdfPDF document, 36.8 KB Supplementary Figure 2. Purification of CD8+ and CD4+ T cells.

Dec 30, 2023 | mdpi.com | Michihisa Kono |Ryosuke Sato |Hiroki Komatsuda |Risa Wakisaka

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Aug 4, 2023 | frontiersin.org | Takumi Kumai |Rong-Hui Xia |Michihisa Kono

1 IntroductionIn 2010, Skalova et al. reported a histological type of salivary gland carcinoma that resembled the secretory carcinoma (SC) of the mammary gland, known as mammary analog secretory carcinoma (MASC) (1). Recently, MASC was established as a new histologic type in the World Health Organization Classification of Head and Neck Tumors (4th edition) as SC (2). SCs are low-grade salivary gland tumors that grow relatively slowly (1, 3, 4); however, there is currently no effective drug therapy.